Speciality Medicines inks commercial agreement valued at USD 2 million

April 23, 2026 · 1:31 pm IST Source: Business Standard
๐Ÿ“Œ

Key Takeaways

  • Under the said deal, the said entity has agreed to distribute, market and sell the products of the company of value of USD 2 million (an approximate value of Rs 18.8 crore).

Full Report

Speciality Medicines has finalized a commercial arrangement with an international entity that specializes in importing and distributing the pharmaceutical finished products, supporting its future growth. Under the said deal, the said entity has agreed to distribute, market and sell the products of the company of value of USD 2 million (an approximate value of Rs 18.8 crore).

Originally reported by Business Standard.
๐Ÿ’ก

IPO Cracker Take

This market development has implications for IPO investors tracking upcoming issues. See our IPO calendar and live GMP data for the most recent moves.

โ“

Frequently Asked Questions

Market news feeds into IPO pricing decisions, subscription timing, and listing-day sentiment. Track the broader market daily alongside each active IPO's own fundamentals.

Our IPO calendar shows all upcoming, open, and recently listed issues in one place — with price band, GMP, and subscription data.

We publish daily market and IPO news, live GMP updates, and subscription tracking. Bookmark our News page or follow us on social media for real-time updates.
0 Comments

No comments yet. Be the first to share your opinion!